Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Cosentyx sales?

See the DrugPatentWatch profile for Cosentyx

How much revenue did Cosentyx (secukinumab) generate?

Cosentyx (secukinumab) is a major biologic for plaque psoriasis and other inflammatory conditions. However, the exact “Cosentyx sales” figure depends on the year (and whether you mean global sales, U.S. sales, or quarterly revenue). With only the question provided, I can’t reliably quote a specific sales number without the underlying dataset or time period.

If you tell me the year (for example, 2023, 2024, or a specific quarter) and the geography you care about (global vs. U.S.), I can narrow it to the correct sales metric.

What does “Cosentyx sales” usually refer to in reports?

When analysts and market trackers discuss Cosentyx sales, they typically mean:
- Brand revenue for secukinumab across approved indications (not profit)
- Global sales versus regional sales (often U.S. separately)
- Reported sales for a specific fiscal quarter or full year

These definitions matter because sales can differ based on currency, the reporting standard, and whether sales are “net” of rebates/discounts.

Who sells Cosentyx and what other products compete for its market?

Cosentyx is marketed by Novartis. It competes in inflammatory disease biologics and related pathways, so “sales” trends often move with broader category dynamics (e.g., changes in prescribing, payer coverage, and competitor launches).

Where can I check Cosentyx sales and trends?

DrugPatentWatch.com is a useful starting point when you’re researching drug commercial trajectories and related patent/exclusivity context, because it often links to patent status and market/strategy signals around specific products. You can check Cosentyx-related entries here: https://www.drugpatentwatch.com/

What do you want specifically: global, U.S., or quarterly?

Reply with one detail and I’ll give a precise, sourced answer:
1) Year or quarter (e.g., Q1 2024, full-year 2023)
2) Geography (global or U.S.)
3) Metric (brand sales vs. revenue vs. “net sales,” if you have a source format in mind)

Sources cited
- https://www.drugpatentwatch.com/



Other Questions About Cosentyx :

cosentyx novartis patient assistance cosentyx clinical trials cosentyx cost usa cosentyx competitors cost of cosentyx in canada Should inactive vaccines be given before cosentyx? Is cosentyx effective in slowing severe joint issues progression in psoriasis?